Pure Global

IVD Department for Quantitative Blood Glucose Testing - Vietnam Registration 2403233ĐKLH/BYT-HTTB

Access comprehensive regulatory information for IVD Department for Quantitative Blood Glucose Testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403233ĐKLH/BYT-HTTB and manufactured by Roche Diabetes Care GmbH. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403233ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403233ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department for Quantitative Blood Glucose Testing
VN: Bộ IVD xét nghiệm định lượng đường huyết
Risk Class TTBYT Loại C

Registration Details

2403233ĐKLH/BYT-HTTB

17003062/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Roche Diabetes Care GmbH

Technical Details

Blood Glucose Test: The blood glucose test strip, used in conjunction with a dedicated blood glucose meter, is designed to quantify glucose in the blood of patients with microvascular, venous, arterial blood, and the blood of newborns. It is intended for self-monitoring by patients with diabetes and for use by healthcare professionals to perform point-of-care testing on patients. The dedicated blood glucose meter is the Accu-Chek Active. Patients with diabetes can use blood from the microvascular system, freshly obtained from the tip of a finger, or an alternative blood sampling site. Healthcare professionals can use blood from the venous system, which has been anticoagulated with lithium heparin, ammonium heparin, or EDTA, arterial blood, or blood from newborns. The Accu-Chek Active system is intended for the monitoring of blood glucose in diabetes. The Accu-Chek Active system comprises the Accu-Chek Active meter, the Accu-Chek Active test strip, and the Accu-Chek Active control solution. Control Solution for Quantitative Blood Glucose Testing: This control solution is used to assess the performance of the Accu-Chek Active test strip and the dedicated blood glucose meter. It is intended for self-monitoring by patients with diabetes and for use by healthcare professionals to perform point-of-care testing on patients. The dedicated test strip and device are the Accu-Chek Active test strip and the Accu-Chek Active meter.

Dates and Status

Nov 02, 2024